Skin warts during fingolimod treatment in patients with multiple sclerosis
- 1 November 2019
- journal article
- editorial
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 36, 101437
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- HPV-related papillary squamous cell carcinoma of the tonsil during treatment with fingolimodMultiple Sclerosis and Related Disorders, 2018
- Infections in Patients Receiving Multiple Sclerosis Disease-Modifying TherapiesCurrent Neurology and Neuroscience Reports, 2017
- Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trialThe Lancet Neurology, 2014
- Sphingosine 1-phosphate and cancerNature Reviews Cancer, 2010
- Mechanism of Action of Oral Fingolimod (FTY720) in Multiple SclerosisClinical Neuropharmacology, 2010
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple SclerosisNew England Journal of Medicine, 2010
- Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple SclerosisNew England Journal of Medicine, 2010